Alpheus Medical (Series B)
Funding Details
Awarder
Inbox
Date Award
May 15, 2025
Vertical
Oncology
Funding URL
View Funding Page
Funding Amount
$52,000,000
Company Info
Traction
Promising early results from two studies highlighting the potential of SDT therapy in both newly diagnosed and recurrent glioblastoma patients.
Market
Cancer treatment
Location
Chanhassen, Minnesota, United States
Coinvestors
HealthQuest Capital, Samsara BioCapital, OrbiMed, Action Potential Venture Capital, BrightEdge, Brain Tumor Investment Fund, Sontag Innovation Fund
Company Description

Alpheus Medical is a solid body cancer treatment developer that focuses on sonodynamic therapy (SDT) for treating newly diagnosed glioblastoma. The company aims to provide a non-invasive, outpatient treatment option that selectively targets and destroys cancer cells across the entire brain hemisphere.

Links
Website
Back to HomeBack to Oncology DealsView Funding Announcement